The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in ...
Thanks for liking this story! We have added it to a list of your favorite stories. MPR News surveyed candidates in local, state and federal races, and voters in Minnesota can use our tool to get ...
Results The prevalence of UI was 45.3% (n=39), with the average impact on quality of life scored at 6.1±3.5 on ... Drafting the work or reviewing it critically for important intellectual content: PNB, ...